| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |